Orphenadrine Citrate Tablet, Extended Release
Product Images NDC 63187-632

2 FDA label images from Proficient Rx Lp · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Orphenadrine Citrate (NDC 63187-632). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (8120fe4d 7799 4de6 Bf2f F8c8721d11ae 01)

Chemical Structure (8120fe4d 7799 4de6 Bf2f F8c8721d11ae 01)
Chemical structure diagram showing the molecular formula and structure of Orphenadrine Citrate, including element symbols and bond formations, as well as its molecular weight of 461.51.*
FDA Label Image

63187-632-30 (8120fe4d 7799 4de6 Bf2f F8c8721d11ae 02)

63187-632-30 (8120fe4d 7799 4de6 Bf2f F8c8721d11ae 02)
Label for Orphenadrine Citrate 100 mg extended-release tablets, 30 count, by Proficient Rx LP. The label includes the NDC 63187-632-30 and states the product is for RX only. It identifies the manufacturer as Sandoz Inc., Princeton, NJ, and provides storage information at 20°-25°C. Tablets are described as white, round, debossed with "E" over "22" on one side.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.